Industry2h ago
Chai Discovery Hits $4B Valuation
Four major AI pharma tool deals closed during the JPM conference in San Francisco. Chai Discovery, backed by OpenAI, reached a $4B valuation just two years after founding. This shift indicates pharmaceutical companies are now prioritizing direct tool acquisitions over traditional partnerships. Practitioners should watch for increased consolidation in the BioAI sector.